assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 10 mg (880229P-10mg), pkg of 1 × 100 mg (880229P-100mg), pkg of 1 × 25 mg (880229P-25mg), pkg of 1 × 50 mg (880229P-50mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand
lipid type
polymerizable lipids
click reagents
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP([O-])(OCCNC(OCCOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO/C=C\NC(CCC(N1CC(C=CC=C2)=C2C#CC3=C1C=CC=C3)=O)=O)=O)=O)(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C
General description
DSPE-PEG(2000)-DBCO is a functionalized polyethylene glycol (PEG) lipid conjugate.
Application
DSPE-PEG(2000)-DBCO has been used in the preparation of peptide conjugated fluorescent nanoparticle by modified thin-film hydration technique. It has also been used for homeotropic anchoring of the mesogen molecules.
Packaging
5 mL Amber Glass Screw Cap Vial (880229P-100mg)
5 mL Amber Glass Screw Cap Vial (880229P-10mg)
5 mL Amber Glass Screw Cap Vial (880229P-25mg)
5 mL Amber Glass Screw Cap Vial (880229P-50mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
wgk
WGK 3
저장 등급
11 - Combustible Solids
flash_point_f
No data available
flash_point_c
No data available
Active nematic emulsions
Guillamat BP, et al.
Science Advances, 4(4) (2018)
Active nematic emulsions
Guillamat BP, et al.
Science advances, 4(4) (2018)
A novel nanoparticle delivery system for targeted therapy of noise-induced hearing loss
Kayyali MN, et al.
J. Controlled Release, 279, 243-250 (2018)